RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
1.060
0.00 (0.00%)
At close: May 12, 2025, 4:00 PM
1.060
0.00 (0.00%)
After-hours: May 12, 2025, 5:19 PM EDT

RenovoRx Statistics

Total Valuation

RenovoRx has a market cap or net worth of $38.74 million. The enterprise value is $31.86 million.

Market Cap 38.74M
Enterprise Value 31.86M

Important Dates

The next confirmed earnings date is Thursday, May 15, 2025, after market close.

Earnings Date May 15, 2025
Ex-Dividend Date n/a

Share Statistics

RenovoRx has 36.55 million shares outstanding. The number of shares has increased by 116.42% in one year.

Current Share Class 36.55M
Shares Outstanding 36.55M
Shares Change (YoY) +116.42%
Shares Change (QoQ) +0.67%
Owned by Insiders (%) 4.36%
Owned by Institutions (%) 6.37%
Float 29.20M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 900.92
Forward PS n/a
PB Ratio 5.69
P/TBV Ratio 8.65
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 741.01
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.10, with a Debt / Equity ratio of 0.06.

Current Ratio 4.10
Quick Ratio 3.77
Debt / Equity 0.06
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -1,192.69% and return on invested capital (ROIC) is -780.89%.

Return on Equity (ROE) -1,192.69%
Return on Assets (ROA) -143.08%
Return on Invested Capital (ROIC) -780.89%
Return on Capital Employed (ROCE) -176.68%
Revenue Per Employee $4,300
Profits Per Employee -$881,400
Employee Count 10
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -26.90% in the last 52 weeks. The beta is 1.12, so RenovoRx's price volatility has been higher than the market average.

Beta (5Y) 1.12
52-Week Price Change -26.90%
50-Day Moving Average 0.96
200-Day Moving Average 1.11
Relative Strength Index (RSI) 60.35
Average Volume (20 Days) 117,444

Short Selling Information

The latest short interest is 250,265, so 0.68% of the outstanding shares have been sold short.

Short Interest 250,265
Short Previous Month 295,074
Short % of Shares Out 0.68%
Short % of Float 0.86%
Short Ratio (days to cover) 2.18

Income Statement

In the last 12 months, RenovoRx had revenue of $43,000 and -$8.81 million in losses. Loss per share was -$0.40.

Revenue 43,000
Gross Profit 43,000
Operating Income -10.97M
Pretax Income -8.05M
Net Income -8.81M
EBITDA n/a
EBIT -10.97M
Loss Per Share -$0.40
Full Income Statement

Balance Sheet

The company has $7.15 million in cash and $278,000 in debt, giving a net cash position of $6.88 million or $0.19 per share.

Cash & Cash Equivalents 7.15M
Total Debt 278,000
Net Cash 6.88M
Net Cash Per Share $0.19
Equity (Book Value) 4.48M
Book Value Per Share 0.19
Working Capital 5.92M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$9.13 million and capital expenditures -$12,000, giving a free cash flow of -$9.14 million.

Operating Cash Flow -9.13M
Capital Expenditures -12,000
Free Cash Flow -9.14M
FCF Per Share -$0.25
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -25,511.63%
Pretax Margin -20,497.67%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

RenovoRx does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -116.42%
Shareholder Yield n/a
Earnings Yield -22.75%
FCF Yield -23.59%

Analyst Forecast

The average price target for RenovoRx is $7.00, which is 560.38% higher than the current price. The consensus rating is "Strong Buy".

Price Target $7.00
Price Target Difference 560.38%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) 397.27%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

RenovoRx has an Altman Z-Score of -7.94 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -7.94
Piotroski F-Score 1